These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18304527)

  • 1. Electrophysiologic effects of systemic and locally infused epibatidine on locus coeruleus neurons.
    Ganesh A; Gonzalez-Sulser A; Chaijale N; Cucchiaro G
    Eur J Pharmacol; 2008 Apr; 584(1):93-9. PubMed ID: 18304527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
    Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
    Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The locus coeruleus nucleus as a site of action of the antinociceptive and behavioral effects of the nicotinic receptor agonist, epibatidine.
    Cucchiaro G; Chaijale N; Commons KG
    Neuropharmacology; 2006 Jun; 50(7):769-76. PubMed ID: 16460769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine.
    Cucchiaro G; Chaijale N; Commons KG
    J Pharmacol Exp Ther; 2005 Apr; 313(1):389-94. PubMed ID: 15608080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception.
    Flores CM; Wilson SG; Mogil JS
    Pharmacogenetics; 1999 Oct; 9(5):619-25. PubMed ID: 10591542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
    Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
    J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (+/-) Epibatidine increases acetylcholine release partly through an action on muscarinic receptors.
    Kommalage M; Höglund AU
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):238-44. PubMed ID: 15125694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.
    Khan IM; Buerkle H; Taylor P; Yaksh TL
    Neuropharmacology; 1998 Dec; 37(12):1515-25. PubMed ID: 9886674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats.
    Yousofizadeh S; Tamaddonfard E; Farshid AA
    Eur J Pharmacol; 2015 Jul; 758():147-52. PubMed ID: 25864612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
    Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice.
    Damaj MI; Martin BR
    Eur J Pharmacol; 1996 Apr; 300(1-2):51-7. PubMed ID: 8741164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxide.
    Ruiz-Durántez E; Ruiz-Ortega JA; Pineda J; Ugedo L
    Br J Pharmacol; 2002 Mar; 135(5):1152-8. PubMed ID: 11877321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 4 nicotinic acetylcholine receptor subunit links cholinergic to brainstem monoaminergic neurotransmission.
    Cucchiaro G; Commons KG
    Synapse; 2003 Sep; 49(3):195-205. PubMed ID: 12774304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinally mediated analgesia and receptor binding affinity of epibatidine analogs.
    Nishiyama T; Gyermek L; Trudell ML; Hanaoka K
    Eur J Pharmacol; 2003 May; 470(1-2):27-31. PubMed ID: 12787827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine-stimulated release of [3H]norepinephrine from fetal rat locus coeruleus cells in culture.
    Gallardo KA; Leslie FM
    J Neurochem; 1998 Feb; 70(2):663-70. PubMed ID: 9453560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperalgesic activity of epibatidine in the formalin model of facial pain.
    Gilbert SD; Clark TM; Flores CM
    Pain; 2001 Jan; 89(2-3):159-65. PubMed ID: 11166471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites.
    Ulrich YM; Hargreaves KM; Flores CM
    Neuropharmacology; 1997 Aug; 36(8):1119-25. PubMed ID: 9294978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional neurochemical evidence for the presence of presynaptic nicotinic acetylcholine receptors at the terminal region of myenteric motoneurons: a study with epibatidine.
    Mandl P; Kiss JP; Vizi ES
    Neurochem Res; 2003 Apr; 28(3-4):407-12. PubMed ID: 12675123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.